| Q64058836 | 7-Pyrrolidinethoxy-4'-Methoxyisoflavone Prevents Amyloid β-Induced Injury by Regulating Histamine H3 Receptor-Mediated cAMP/CREB and AKT/GSK3β Pathways |
| Q37151152 | A single-point mutation (Ala280Val) in the third intracellular loop alters the signalling properties of the human histamine H₃ receptor stably expressed in CHO-K1 cells. |
| Q40041186 | Agonist-induced activation of histamine H3 receptor signals to extracellular signal-regulated kinases 1 and 2 through PKC-, PLD-, and EGFR-dependent mechanisms |
| Q21093341 | Antagonist affinity measurements at the Gi-coupled human histamine H3 receptor expressed in CHO cells |
| Q42947904 | Antinociceptive effects of histamine H3 receptor antagonist in the preclinical models of pain in rats and the involvement of central noradrenergic systems |
| Q48445183 | Brain pharmacokinetics of non-imidazole biphenyl H3 receptor antagonists: a liquid chromatography/electrospray-mass spectrometry and ex vivo binding study in rats. |
| Q42020167 | Comparison of the pharmacological properties of human and rat histamine H3-receptors |
| Q42465337 | Development of time-resolved fluorescent based [EU]-GTP binding assay for selection of human Histamine 3 receptor antagonists/inverse agonist: a potential target for Alzheimer's treatment |
| Q34139724 | Discovery of Histamine H3 Antagonists for the Treatment of Cognitive Disorders and Alzheimer's Disease |
| Q36302995 | Effect of histamine on Ca(2+)-dependent signaling pathways in rat conjunctival goblet cells |
| Q43291305 | Effects of splice sites on the intron retention in histamine H3 receptors from rats and mice |
| Q34458579 | H3 Receptors and Pain Modulation: Peripheral, Spinal, and Brain Interactions |
| Q37808205 | Histamine H3 Receptor as a Drug Discovery Target |
| Q38023551 | Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives. |
| Q21129323 | Histamine neurons in the tuberomamillary nucleus: a whole center or distinct subpopulations? |
| Q42490674 | Histamine receptor expression, hippocampal plasticity and ammonia in histidine decarboxylase knockout mice |
| Q36844223 | Histamine-induced itch and its relationship with pain |
| Q42370925 | Hybrid approach to structure modeling of the histamine H3 receptor: Multi-level assessment as a tool for model verification |
| Q28481970 | Identification and characterization of ZEL-H16 as a novel agonist of the histamine H3 receptor |
| Q90399887 | Influence of the Novel Histamine H3 Receptor Antagonist/Inverse Agonist M39 on Gastroprotection and PGE2 Production Induced by (R)-Alpha-Methylhistamine in C57BL/6 Mice |
| Q36231984 | Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion, and epithelial-to-mesenchymal transition |
| Q101410024 | Inhibition of histamine receptor H3 suppresses the growth and metastasis of human non-small cell lung cancer cells via inhibiting PI3K/Akt/mTOR and MEK/ERK signaling pathways and blocking EMT |
| Q26827568 | International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors |
| Q37469102 | Molecular and biochemical pharmacology of the histamine H4 receptor |
| Q26746056 | Multiple Targeting Approaches on Histamine H3 Receptor Antagonists |
| Q92581971 | Pharmacokinetics, excretion and metabolites analysis of DL0410, a dual‑acting cholinesterase inhibitor and histamine‑3 receptor antagonist |
| Q38212433 | Procognitive properties of drugs with single and multitargeting H3 receptor antagonist activities |
| Q38640425 | Qsar Modeling Of Histamine H3r Antagonists/Inverse Agonists As Future Drugs For Neurodegenerative Diseases |
| Q40208576 | Recent advances in the development of histamine H3 antagonists |
| Q38909178 | Role of histamine H3 receptor in glucagon-secreting αTC1.6 cells |
| Q37944920 | Several down, a few to go: histamine H3 receptor ligands making the final push towards the market? |
| Q38937634 | The Histamine H3 Receptor: Structure, Pharmacology, and Function |
| Q24654788 | The histamine H3 receptor: an attractive target for the treatment of cognitive disorders |
| Q38107173 | The neglected role of histamine in Alzheimer's disease. |